ArticleOncotarget2018

Modeling and antitumor studies of a modified L-penetratin peptide targeting E2F in lung cancer and prostate cancer.

Tazeem Shaik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.